Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung

Clinical trial NCT01236716 · COMPLETED

Trial details

NCT number: NCT01236716
Sponsor: Chinese Society of Lung Cancer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2010-11-01
Primary completion: 2013-12-01
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.